We introduced a functional p16 cDNA into non-small cell lung cancer (NSCLC) cell lines expressing dierent combinations of normal and mutated p16, p53, and Rb genes via a recombinant adenovirus to determine the eect of exogenous p16 expression on cell growth. Analysis of p16-de®cient cells infected with Adv/p16 identi®ed growth arrest of the cells in the G 0 ± G 1 phase early on. Apoptosis was identi®ed to occur by the 5th day after infection which corresponded with increased p16 expression, reduced Rb expression, and increased Rb hypophosphorylation, but only occurred in cells expressing functional p53. Further analysis indicated that the expression of the anti-apoptotic protein bcl-2 was greatly reduced in the NSCLC cell lines H460 and A549 (both 7p16, +p53, +Rb), again only by the 5th day after Adv/p16 infection, but no aect on Bax expression was observed. H1299 cells (7p16, 7p53, +Rb) infected with Adv/p16 only exhibited apoptosis by an additional infection with Adv/p53 which also corresponded with a down-regulation of bcl-2. In addition, the infection of A549 cells with Adv/p16 followed by a subsequent infection with Adv/Rb lead to a signi®cant decrease in apoptosis which correlated with an increase in bcl-2 expression. These studies suggest that p16 is capable of mediating apoptosis in NSCLC cell lines expressing wild-type p53, through a direct down-regulation of Rb and an indirect down-regulation of the anti-apoptotic protein bcl-2. Oncogene (2000) 19, 1589 ± 1595.
Introduction

p16
INK4 has been identi®ed as a tumor suppressor protein acting as an inhibitor of the cyclin-dependent kinase (cdk) 4:cyclin D complex (Weinberg, 1995) . Alterations in p16 gene expression have been observed in numerous tumor cell lines and in many fresh tumors, especially those related to the lung (Otterson et al., 1994; Sakaguchi et al., 1996) . Many Rb-positive NSCLC's express little or no p16, while Rb-negative NSCLC's express abundant p16 (Shapiro et al., 1995) . As a result, inactivation of either p16 or Rb appear to be a critical step in the pathway leading to a malignant phenotype in vivo. Another tumor suppressor gene that is a critical component of many cellular pathways is p53, which functions as a regulator of a DNA damagetriggered G 1 checkpoint (Hartwell and Kastan, 1994) . The p53-mediated check of DNA damage can be mediated by the transcriptional activation of p21, which inhibits cdk-mediated Rb phosphorylation, leading cells to an arrest in G 1 and thus giving the cell time to repair DNA-damage (Demers et al., 1994) . p53 can also activate the expression of Bax (a cell death inducer) and mediate suppression of bcl-2 (a cell death inhibitor), leading to cellular apoptosis (Miyashita et al., 1994) . This induction occurs through the Bax protein forming a heterodimer with bcl-2, and thus inactivating the bcl-2 protein. As a result, it has been suggested that the ratio of Bax to bcl-2 determines survival or death of a cell following an apoptotic signal (Miyashita et al., 1994) . Recent studies have now demonstrated that p16 may contribute to the induction of apoptosis in hepatocellular and colon carcinoma cell lines (Sandig et al., 1997) . In addition, studies have identi®ed that the p53 and Rb pathways may interact by p53 transcriptionally regulating Rb expression or in more recent ®ndings through interactions with MDM-2 and p14 (Shio et al., 1992; Hsieh et al., 1999; Bates et al., 1998) . However, it is still unclear as to exactly how these pathways interact, what contributes to p16-mediated apoptosis, and if it is a universal pathway for apoptosis induction in all cancer cells. To begin to address these questions, we have attempted to de®ne if p16-mediated apoptosis occurs in NSCLC cell lines and in the context of these cells, what the initial requirements are for interactions between p16 and other related proteins such as Rb, p53, and bcl-2. We demonstrate in this paper an expansion of our initial ®ndings that p16 is able to induce apoptosis in NSCLC cells (Kataoka et al., 1996) . We have identi®ed that p16 is capable of mediating apoptosis in NSCLC cell lines that contain functional p53 and that this process may be related to not only a down-regulation/hypophosphorylation of Rb, but a reduction in expression of the anti-apoptotic protein bcl-2 as well. These ®ndings now provide additional evidence that p16 is able to mediate apoptosis and adds further proof that p16 may contribute to the interaction between the Rb and p53 pathways.
Results
To determine whether the expression of p16 had an eect on the growth proliferation of NSCLC cell lines we infected the cell lines A549 (7p16, +p53, +Rb), H1299 (7p16, 7p53, +Rb), and H596 (+p16, 7p53, 7Rb) with Adv/p16. This resulted in growth suppression as early as 3 days after infection in the cell lines A549 and H1299 whereas the control vector Adv/b-gal had little eect on growth ( Figure 1A,B) . Little or no eect on cell growth was demonstrated in the cell line H596 ( Figure 1C) . Unexpectedly, the proliferation of A549 cells between days 5 and 7 actually decreased, while the proliferation of H1299 cells increased during this time. We expanded on this observation to ®rst determine the eect of p16 expression on the cell cycle.
Flow cytometric analysis of the cell cycle for Adv/p16 infected A549 and H1299 cells identi®ed an increase in the percentage of cells in the G 0 ± G 1 phase by day 3 as compared to control infected cells (Table 1) . By day 5, there was a decrease in the percentage of cells in the G 0 ± G 1 phase that was more apparent in H1299 cells than in A549 cells. However, the cell cycle pro®le in A549 cells on day 5 was not much dierent than control infected cells.
We next determined if the cause of the decline in cell proliferation was due to apoptosis. Initially, the TUNEL assay was performed on both cell lines grown on chamber slides to quantify the number of apoptotic cells (Table 2) . No apoptosis was identi®ed on the 3rd day after infection with Adv/p16. However, on the 5th day after infection, the cell line A549 exhibited a higher number of apoptotic cells in situ as compared to both Adv/b-gal infected cells and H1299 cells infected with Adv/p16. To con®rm this ®nding, both cell lines were infected with appropriate viruses and then analysed by TUNEL FACS. The comparison of data from both assays indicated that the TUNEL in situ analysis provided similar results to TUNEL FACS (Table 2) . Annexin V-Fluorescein Isothiocyanate staining was also used as a second method of measuring apoptosis and this demonstrated signi®cant levels in A549 cells, but little or no apoptosis in H1299 cells (data not shown).
In comparing the status of various tumor suppressors and related proteins in the cell lines A549 and H1299, we noted that A549 cells exhibit wild-type p53 expression while in H1299 cells, p53 expression is absent. Therefore, we attempted to assess whether p53 status was having an eect on p16-mediated apoptosis. A total of seven NSCLC cell lines, in which the p53 status varied, were infected with Adv/p16 and then analysed by the in situ TUNEL assay, since this was a fast and simple method for analysing both attached and¯oating cells and provided results that correlated well with the data from TUNEL FACS. The proper MOI to obtain 70 ± 80% transduction on each cell line was previously determined by Adv/b-gal transduction studies. No signi®cant positive TUNEL staining was seen on day 3 in all cell lines tested ( Table 2 ). The cell lines A549 and H460, which both have normal p53 expression, showed positive TUNEL staining on the 5th day after infection with Adv/p16. The percentage of positive staining cells was signi®cantly more than cells treated with Adv/b-gal. The other cell lines, which are either deleted for or express mutant p53, did not show any signi®cant amount of TUNEL positive cells after infection with either Adv vector. This indicated that p16 was only able to induce apoptosis in cells containing wild-type p53 and that this process did not occur early after Adv/p16 infection.
To determine the proteins that may be contributing to the p16 induced apoptosis, Western blot analysis was done using lysates of the p53 normal A549 cells that had been infected with Adv/p16 ( Figure 2) . Analysis of the blots with the p16 polyclonal antibody indicated that strong p16 protein expression occurred 2 days after infection, which continued at high levels at least until day 7. Cell cycle analysis indicated that the p16 protein was functional as seen by a G 0 ± G 1 arrest in these cells during this time period (Table 1 ). In addition to high level p16 expression, the Rb protein exhibited hypophosphorylation, again indicating that p16 protein was functioning correctly. Also, Rb expression became markedly reduced by day 7. We also analysed the expression of p53 and bcl-2, since each has been directly implicated in apoptosis. The expression of p53 was up-regulated by the infection with Adv/p16 on days 3 ± 5 in A549 cells (Figure 2 ), but this was no dierent than the increase that occurred with Adv/b-gal infected cells (data not shown). Nevertheless, bcl-2 protein levels were greatly reduced in A549 cells treated with Adv/p16 by the ®fth day after infection whereas there was no change in bcl-2 levels in cells treated with Adv/b-gal (data not shown). In addition, the reduction in bcl-2 levels seem to coincide with the reduction in Rb levels. The levels of Bax protein expression was not changed after infection with Adv/p16 (data not shown).
We also compared the levels of these proteins in A549 cells to levels in the cell line H1299 (deleted for p53 expression), looking speci®cally at day 5 where signi®cant apoptosis had been demonstrated ( Figure  3A ). While high level p16 protein expression as well as hypophosphorylated and reduced Rb protein expression was noted in both cell lines, p53 protein expression was only seen in A549 cells, since the p53 gene is deleted in the cell line H1299. Interestingly as well, bcl-2 protein expression, which was greatly reduced in A549 cells treated with Adv/p16, was unchanged in cells treated with Adv/b-gal or in H1299 cells treated with Adv/p16. The levels of Bax protein expression was not changed for either cell line after infection with Adv/p16 (data not shown). To con®rm the role of bcl-2 down-regulation in p16-mediated apoptosis, we also analysed cell lysates from the cell line H460 that had been infected 5 days earlier with Adv/p16. Analysis of a Western blot for bcl-2 levels in these cells demonstrated a down-regulation of bcl-2 expression ( Figure 3B ).
Further analysis of the role of p16, p53 and bcl-2 in the induction of apoptosis was also performed. H1299 cells were infected with a combination of Adv/p16 and Adv/ p53 and then analysed by TUNEL in situ. Three days after infection of H1299 cells with either Adv/b-gal or Adv/p16, the cells were infected with either Adv/b-gal or Adv/p53 (MOI of 1=30% transduction). Cells were then harvested 2 days after the second infection and then TUNEL in situ was performed. Only the cells that were initially infected with Adv/p16, followed by a second infection with Adv/p53 exhibited positive staining for apoptosis that was signi®cantly higher than other treated cells ( Figure 4A ). To ensure that this induction of apoptosis was due to both the expression of p16 and p53 and to con®rm that a reduction of bcl-2 was involved, Western blot analysis was done on lysates from the cells analysed in Figure 4A . High level p16 and p53 expression could be identi®ed in cells treated with either Adv/p16 and/or Adv/p53 ( Figure 4B ). More importantly, analysis of bcl-2 levels in the Adv/p16+Adv/p53 infected cells demonstrated a decrease in expression levels as compared to control and untreated cells. This again indicates that p16-induced apoptosis occurs in the presence of wild-type p53 and is related to a reduction in bcl-2 levels.
To further con®rm the role of Rb in p16-mediated apoptosis and to determine whether the expression of Rb can inhibit apoptosis, we analysed Adv/p16 infected A549 cells. These cells were infected with Adv/Rb on the third day after the initial infection with Adv/p16 and then analysed by TUNEL in situ 2 days later ( Figure 5A ). The treated cells exhibited a 38 ± 43% reduction in levels of apoptosis as compared to Adv/p16 only and Adv/p16+Adv/b-gal infected cells. To further analyse the eect of replacing Rb expression in these cells, lysates of the Adv/p16+Adv/Rb infected cells were analysed by Western blotting ( Figure 5B ). The analysis identi®ed that in addition to an increase in Rb expression, bcl-2 expression in the cells was also increased.
Discussion
We have demonstrated that the exogenous expression of functional p16 in NSCLC cells lacking p16, but containing wild-type p53, results in these cells undergoing programmed cell death or apoptosis. This process is directly related to a reduction in both Rb and the anti-apoptotic protein bcl-2. Previous reports in the literature have identi®ed that adenovirusmediated p16 gene transfer can result in growth suppression by a G 0 ± G 1 arrest as mediated by an increased hypophosphorylation of the Rb protein (Jin et al., 1995) . Our analysis shows similar results, but also indicates that prolonged expression of the p16 protein can result in other eects on the cell including apoptosis. This process seems to be dependent upon a critical amount and length of p16 expression since it was only identi®ed 5 days after the initial Adv/p16 infection. The point at which high level p16 expression occured correlated well with the point at which both Rb and bcl-2 down-regulation became apparent, but variability in the degree of this aect may occur (Wang and Walsh 1996) . A recent report also suggests that p16 can act to inhibit apoptosis in murine myocytes and that Rb may be an important control protein associated with this process (Wang et al., 1997 ). An important factor in these latter studies is the lack of disruption of tumor suppressor pathways in these normal cells. The contribution of Rb to apoptosis inhibition was originally demonstrated in the developing mouse lens, but more recently it has been shown to occur in the developing mouse nervous system as well as in human bladder tumor cells (Morgenbesser et al., 1994; Macleod et al., 1996; McConkey et al., 1996) . Studies have demonstrated that this process appears to be associated with Rb complexing with cellular proteins such as the transcription factor E2F1 (Shan et al., 1996) . The expression of p16 that we obtained is probably higher than naturally occurring levels, but this level is probably important in overcoming the anti-apoptotic aect of Rb. This is similar to p53 gene therapy, where mutant p53 expression is overcome by p53 overexpression (Zhang et al., 1994) . In agreement with our studies, a recent report identi®ed that the combination of adenoviral-mediated p16 and p53 expression can result in apoptosis both in vitro and in vivo when performed with hepatocellular and colon carcinoma cell lines (Sandig et al., 1997) . However, in this analysis, the apoptosis may have only occurred through a down-regulation of the Rb protein since the eect on expression of bcl-2 was not presented (Sandig et al., 1997) . In contrast, our results demonstrate a down-regulation of the bcl-2 protein in Adv/p16 infected cells which is p53 and Rb dependent. While this possibly represents two dierent pathways for this mechanism to occur, a further analysis of this ®nding in cell lines from other tumor types is warranted to determine if this is tumor speci®c and whether other apoptosis related proteins are involved. Recent studies in ovarian cancer have demonstrated that p16 can transcriptionally down-regulate Rb expression, but no studies related to apoptosis were presented (Fang et al., 1998) . Another recent report has also demonstrated that p16 can induce apoptosis in lung cancer cell lines (Naruse et al., 1998) . However, apoptosis was only demonstrated when the cells were super-infected using very high MOI (equaling 100% transduction) with a p16 adenovirus. While high levels of p16 were achieved, the super-infection lead to very high levels of cytotoxicity and a signi®cant degree of apoptosis irrelevant of p53 gene status. This suggests that viral toxicity played an important role and raises questions of speci®city in such an approach. In contrast, we purposely maintained maximum transduction levels at 70 ± 80% or less to ensure that vector related toxicity would not become apparent while still expressing sucient levels of p16. This was con®rmed by the lack of vector related toxicity when the control virus Adv/bgal was used.
While we have demonstrated that p16 is capable of inducing apoptosis in NSCLC cells, the exact interaction between p16, p53, Rb, and bcl-2 must be determined. In addition, further analysis of other proteins that control or regulate this group, must also be analysed. Studies have identi®ed that p53 is capable of transcriptionally regulating Rb expression through binding sites in the Rb promoter (Shiio et al., 1992) . This is a very important point in p53 acting as thè guardian of the genome', where the protein is involved in regulating many dierent pathways. More recent studies have implicated Rb in the regulation of p53 through interactions with MDM-2 and p14 indicating that there may be a complex interaction between these two pathways that has many dierent contributing proteins (Hsieh et al., 1999; Bates et al., 1998) . In addition, recent studies have implicated p21 as a potential point of control between the Rb and p53 pathways (Mitra et al., 1999) . Thus, it may become apparent that the ratio of Rb and p53 is a critical determinant as to whether growth arrest or apoptosis occurs in the cell. As a result, proteins such as p16, that aect this balance may become critical determinants of which process occurs. A simple pathway as we have described of p16 over-expression, which results in Rb hypophosphorylation and down-regulation, thus freeing up p53 to down-regulate bcl-2 will certainly become more complex with time. While a great number of reports have implicated a down-regulation of bcl-2 in the induction of apoptosis, a link between p16, p53, Rb and bcl-2 as we have demonstrated will require further analysis to elucidate the exact mechanism, providing further insight into the process of programmed cell death as well as the development of improved therapeutics.
Materials and methods
Cell lines
The human non-small lung carcinoma cell lines H1299, H460, H596, H226br, H322, A549 and H358 were gifts from Drs Adi Gazdar and John Minna. The mutational status of the p53, p16, and Rb genes in each cell line are shown in Table 2 ( Mitsudomi et al., 1992; Noble et al., 1992) .
Adenoviral vectors and infection of cells
All recombinant adenoviral vectors are based on adenovirus serotype 5 with gene insertion into the E1 region of the viral genome. The adenovirus containing the E. coli b-galactosidase gene driven by the cytomegalovirus (CMV) enhancer/ promoter (Adv/b-Gal), was a gift of Dr Frank L Graham (McMaster University, Ontario, Canada). The adenovirus containing either the human wild type p16 cDNA (Adv/p16) or the human wild type p53 cDNA (Adv/p53) both driven by the CMV enhancer/promoter have been described previously (Jin et al., 1995; Zhang et al., 1994) . The adenovirus containing the retinoblastoma cDNA (Adv/Rb) driven by the CMV enhancer/promoter was a gift of Dr Ta-Jen Liu (University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA). The recombinant adenovirus was propagated, puri®ed, and titered as described previously (Spitz et al., 1996) . All cell lines were incubated with the Adv vectors for 48 h at MOI that resulted in 70 ± 80% transduction, unless otherwise noted.
Western blot analysis
Total cell lysates were prepared by lysing non-con¯uent monolayer cells in dishes followed by electrophoresis on SDS ± PAGE using 10 mg of protein per lane. Following electrophoresis, the proteins in the gel were transferred to Hybond-ECL membrane (Amersham International, Little Chalfont, Buckinghamshire, UK) and incubated with either a 1 : 800 dilution of rabbit anti-human p16 polyclonal antibody (C-20) (Santa Cruz Biotechology, Inc. Santa Cruz, CA, USA), a 1 : 250 dilution of mouse anti-human Rb monoclonal antibody (G3-245) (Pharmigen, San Diego, CA, USA), a 1 : 250 dilution of mouse anti-human p53 (DO-7) (Pharmigen, San Diego, CA, USA), a 1 : 500 dilution of mouse anti-human bcl-2 (124) (DAKO Corp., Carpintenia, CA, USA), or a 1 : 2000 dilution of mouse anti-human actin monoclonal antibody (N 350) (Amersham International, Little Chalfont, Buckinghamshire, UK). The membranes were developed according to Amersham's ECL Western blotting protocol. In all Western blot analysis, b-actin was used as a loading control.
Cell proliferation assay and cell cycle analysis
Cell proliferation assays were carried out in microtiter plates. A549 and H1299 cells were plated at 1 ± 2610 3 cells/well and grown for 2 days. After infection with Adv vectors, the cells were harvested at various time points and then treated with tetrazolium compound and phenazone methosulfate using the Titer 96 TM aqueous non-radioactive cell proliferation assay kit (Promega, Madison, WI, USA). The number of viable cells was determined by the absorbance of formazan at 490 nm by using a MRX microplate reader (Dynatech Laboratories, Chantilly, VA, USA) at each time point. Cell cycle analysis was performed on Adv infected cells at appropriate time points using previously published procedures (Jin et al., 1995) .
TUNEL assay in situ and by flow cytometry
Apoptotic cells were detected by modi®cation of a previously described TUNEL technique (Gavrieli et al., 1992) . For in situ analysis, cells were seeded and grown in chamber slides, infected with Adv, and then analysed for TUNEL staining at appropriate time points. After staining, the cells were counterstained with Harris hematoxylin (Sigma, St Louis, MO, USA). The percentage of positive cells was determined by counting 500 cells from nine ®elds on each slide. For the TUNEL analysis by¯ow cytometry, the cells were ®xed in 1% formaldehyde in PBS, washed with PBS, and then resuspended in 70% ice-cold ethanol, and stored at 48C until used. TUNEL assay for¯ow cytometry was performed according to the procedure of Gorezyca et al. (1993) . All samples were analysed with the use of an EPICS Pro®le IĪ ow cytometer (Coulter Corporation, Hialeath, FL, USA). An analysis region was set based on the negative control for each sample, with the percentage of labeled cells being calculated from this region. A minimum of 10 000 events per sample was analyzed and FITC¯uorescence was collected using a 525BP ®lter. Coulter's Cytologic program was used for data analysis. Mean peak¯uorescence was determined for each histogram.
Statistical analysis
The dierences in data were analysed for statistical signi®cance using the Mann-Whitney test; a P value of 50.05 was considered to indicate statistical signi®cance. All experiments were repeated at least twice with the results of three independent experiments presented where possible. 
